CTLA4 and hematocrit: Some studies have found a reduced expression of CD152 in individuals with HT, which suggests that TLs have defects in the expression of CD152 which abnormally activate TLs, leading to the increased secretion of thyroid autoantibodies [116,117,118,119,120].